Cas 75330-75-5 Lovastatin Api Active Pharmaceutical Ingredient Powder Cardiovascular System Drugs

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Your demand
Delivery Time: Negotiation
Payment Terms: D/P, D/A, L/C, T/T
Supply Ability: Negotiation
Cas No: 75330-75-5 Ec No: 616-212-7
Name: Lovastatin Synonyms: 1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate
Molecular Formula: C24H36O5 Molecular Weight: 404.54
Melting Point: 175°C Boiling Point: 559.2±50.0°C
Solubility: Ethanol: Soluble9.80-10.20mg/mL Density: 1.12±0.1 G/cm3
Risk Codes: R36/37/38 Safety Description: S22;S24/25
High Light:

Cas No 75330-75-5


lovastatin powder


Lovastatin 75330-75-5

Lovastatin Cas No 75330-75-5 API; cardiovascular and cerebrovascular; Cardiovascular System Drugs


Name Lovastatin
Synonyms 1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate
Molecular Formula C24H36O5
Molecular Weight 404.54
CAS Registry Number 75330-75-5
EINECS Number 616-212-7
Melting point 175°C
Boiling point 559.2±50.0°C
Solubility ethanol: soluble9.80-10.20mg/mL
Density 1.12±0.1 g/cm3
Safety Description S22;S24/25
Risk Codes R36/37/38


Product Description:

Lovastatin is a cardiovascular drug, which can prevent the development of atherosclerosis and reduce the risk of myocardial infarction; It can be made into a new type of lipid regulating drug HMG CoA( β- Oh, β- Methylglutaric acid monoaryl coenzyme A) reductase inhibitor. It can significantly reduce the concentration of serum total cholesterol and hydrolyze to corresponding cholesterol after oral administration β- Hydroxy acid, 3-hydroxy-3-methylglutaryl coenzyme A reductase. It can be used for heterozygous familial hypercholesterolemia, severe and mild primary hypercholesterolemia. It can also be used as an adjunctive drug of diet therapy to reduce the level of high cholesterol and low density protein cholesterol.


Product Use:


Cardiovascular system medication, can prevent the development of arteriosclerosis, reduce the risk of myocardial infarction


Cas 75330-75-5 Lovastatin Api Active Pharmaceutical Ingredient Powder Cardiovascular System Drugs 0Cas 75330-75-5 Lovastatin Api Active Pharmaceutical Ingredient Powder Cardiovascular System Drugs 1


Product Catalogue:


Number Cas Name
1 41859-67-0 Bezafibrate
2 62571-86-2 Captopril
3 113665-84-2 Clopidogrel
4 75847-73-3 Enalapril
5 49562-28-9 Fenofibrate
6 25812-30-0 Gemfibrozil
7 21187-98-4 Glicalzide
8 138402-11-6 Irbesartan
9 83915-83-7 Lisinopril
10 75330-75-5 Lovastatin
11 79902-63-9 Simvastatin
12 87333-19-5 Ramipril
13 144701-48-4 Telmisartan
14 13649-88-2 Deflazacort
15 50-02-2 Dexamethasone
16 2135-17-3 Flumethasone
17 53-03-2 Prednisone



About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.


Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486